JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors by Pennel, KAF, Hatthakarnkul, P, Wood, CS, Lian, G, Al-Badran, SSF, Quinn, JA, Legrini, A, Inthagard, J, Alexander, PG, van Wyk, H, Kurniawan, A, Hashmi, U, Gillespie, MA, Mills, M, Ammar, A, Hay, J, Andersen, D, Nixon, C, Rebus, S, Chang, DK, Kelly, C, Harkin, A, Graham, J, Church, D